Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYSLTR1 | Q9Y271 | 10/20 | 0.72 |
| ▸ | CYSLTR2 | Q9NS75 | 5/20 | 0.72 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.63 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.63 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.61 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.61 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9459951 | 0.97 | CYSLTR1 (0.67) | CYSLTR1CYSLTR2FFAR1AKR1B1ALOX5 | |
| SCHEMBL8645017 | 0.88 | CYSLTR1 (0.70) | CYSLTR1CYSLTR2FFAR1AKR1B1ALOX5 | |
| SCHEMBL8646512 | 0.84 | CYSLTR1 (1.00) | CYSLTR1CYSLTR2FFAR1AKR1B1GPBAR1 | |
| SCHEMBL10735112 | 0.83 | GPBAR1 (0.66) | CYSLTR1CYSLTR2FFAR1AKR1B1ALOX5 | |
| SCHEMBL28298920 | 0.82 | CYSLTR1 (0.79) | CYSLTR1CYSLTR2FFAR1AKR1B1ALOX5 | |
| SCHEMBL8650454 | 0.82 | CYSLTR1 (0.79) | CYSLTR1CYSLTR2FFAR1AKR1B1ALOX5 | |
| SCHEMBL10446560 | 0.80 | CYSLTR1 (0.79) | CYSLTR1CYSLTR2FFAR1AKR1B1ALOX5 | |
| SCHEMBL10690965 | 0.80 | CYSLTR1 (0.76) | CYSLTR1CYSLTR2FFAR1AKR1B1ALOX5 | |
| SCHEMBL8712492 | 0.79 | CYSLTR1 (0.75) | CYSLTR1CYSLTR2FFAR1AKR1B1ALOX5 | |
| SCHEMBL8799848 | 0.79 | ALOX5 (0.70) | CYSLTR1CYSLTR2FFAR1AKR1B1ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0666849-A4 | ARYL AND HETEROARYLMETHOXYPHENYL INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS. | ABBOTT LAB (US) | 1995-12-13 | — | — | EP | disclosed |
| US-RE35096-E | Antilipemic, anticholesterol, arteriosclerosis | MITSUBISHI CHEMICAL CORPORATION (JP) | 1995-11-21 | — | — | US | disclosed |
| EP-0666849-A1 | ARYL AND HETEROARYLMETHOXYPHENYL INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS | ABBOTT LABORATORIES (US) | 1995-08-16 | — | — | EP | disclosed |
| US-5358955-A | Antiinflammatory agents | ABBOTT LABORATORIES (US) | 1994-10-25 | — | — | US | disclosed |
| WO-1994010148-A1 | ARYL AND HETEROARYLMETHOXYPHENYL INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS | ABBOTT LABORATORIES (US) | 1994-05-11 | — | — | WO | disclosed |
| US-5082856-A | Hyperlipemia, arteriosclerosis | MITSUBISHI KASEI CORPORATION (JP) | 1992-01-21 | — | — | US | disclosed |
| EP-0347902-A2 | Pyrrolecarboxylic acid derivatives | Mitsubishi Chemical Corporation (JP) | 1989-12-27 | — | — | EP | disclosed |